| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 387 | 108.245 | 250.166 | 442.582 | 453.761 | 721.055 | 861.935 | 946.986 | 1.222.862 |
| Total Income - EUR | - | 387 | 108.246 | 250.168 | 442.582 | 454.055 | 721.337 | 870.389 | 959.230 | 1.235.078 |
| Total Expenses - EUR | - | 840 | 106.213 | 247.073 | 399.822 | 411.927 | 581.101 | 695.537 | 779.779 | 909.584 |
| Gross Profit/Loss - EUR | - | -453 | 2.033 | 3.095 | 42.760 | 42.128 | 140.236 | 174.851 | 179.452 | 325.494 |
| Net Profit/Loss - EUR | - | -465 | 951 | 593 | 38.334 | 37.905 | 134.700 | 166.532 | 166.029 | 280.980 |
| Employees | - | 1 | 3 | 5 | 3 | 5 | 5 | 7 | 7 | 7 |
Check the financial reports for the company - Montana - Nutraceuticals Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 283 | 5.824 | 4.313 | 3.526 | 1.733 | 12.507 | 26.153 | 26.793 | 18.823 |
| Current Assets | - | 35 | 98.591 | 109.271 | 186.611 | 209.468 | 423.306 | 563.298 | 723.527 | 1.256.793 |
| Inventories | - | 0 | 24.519 | 43.305 | 38.911 | 33.838 | 57.009 | 74.747 | 78.820 | 90.803 |
| Receivables | - | 0 | 71.726 | 59.968 | 117.581 | 134.455 | 204.834 | 257.858 | 239.643 | 563.245 |
| Cash | - | 35 | 2.347 | 5.997 | 30.118 | 41.176 | 161.463 | 230.692 | 405.063 | 602.745 |
| Shareholders Funds | - | -420 | 537 | 1.120 | 39.433 | 76.591 | 198.952 | 166.266 | 329.059 | 278.667 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 738 | 107.489 | 114.581 | 151.395 | 135.806 | 237.176 | 425.178 | 422.561 | 998.479 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4639 - 4639" | |||||||||
| CAEN Financial Year |
4639
|
|||||||||
Comments - Montana - Nutraceuticals Srl